Wishing everyone a happy Dussehra! May this festive season bring you success, prosperity, and inspire new beginnings for the year ahead.
HONOUR
Pharmaceutical Manufacturing
Hyderabad, Telangana 5,061 followers
CDMO for Small Molecules, Phosphoramidites and Specialty Chemicals and Ingredients
About us
Honour is a leading global CDMO and Specialty chemicals & ingredients manufacturer with six facilities set to global standards of safety and quality. With our offerings, Honour Synthesis and Honour Specialty, we are embracing the science of partnership and possibilities. Our 2000+ team delivers excellence to our pharmaceutical and biotechnology partners through unlocking practical solutions. Our commitment to transform everyday life of humankind expands to creating specialty ingredients for electronics and pharmaceutical industries. Upholding the highest Environmental, Social, and Governance standards, we collaborate with stakeholders to foster sustainable, people-centric, and transformative outcomes for our partners.
- Website
-
honourlab.com
External link for HONOUR
- Industry
- Pharmaceutical Manufacturing
- Company size
- 1,001-5,000 employees
- Headquarters
- Hyderabad, Telangana
- Type
- Self-Owned
- Founded
- 2011
- Specialties
- CDMO, Process Chemistry, Specialty Chemicals, Excipients, Reagents, Custom Synthesis, Intermediates, and Electronic Chemicals
Locations
-
Primary
Regd. Office #8-3-166/7/1, Ground Floor, Erragadda
Hyderabad, Telangana 500018, IN
Employees at HONOUR
Updates
-
As CPHI Milan 2024 comes to a close, we’re reflecting on an incredible experience for HONOUR at our first-ever CPHI event. It was a fantastic opportunity to showcase our CDMO solutions, share exciting updates and connect with so many of our valued partners. We’re grateful for the chance to share our vision and explore how we can help accelerate your breakthroughs. Thank you to everyone who stopped by and made this event truly memorable. We look forward to seeing you all again at the next edition in 2025! Krishna Chaitanya K Rathan Prasad Achampeta, Ph.D G V Giri Babu #CPHI #CDMO #innovation #collaboration #ScienceOfPartnershipandPossibilities #pharma
-
Day 3 at CPHI Milan 2024! The past two days at CPHI Milan 2024 have been fantastic! It’s been wonderful connecting with our existing partners, and we’re eager to continue those conversations today while forging new connections. Our senior leadership team is excited to meet with you, so we invite you to stop by and say hello! Stop by Stand #7A26 to explore our recent updates and discover how we can support your projects: - Our new 45,000 ft² state-of-the-art R&D Facility – Check out our video on the big screen to see how this facility enhances our R&D capabilities. - Our 7th Manufacturing Facility – Designed to accelerate your early-phase and mid-phase projects. - New Manufacturing Block at Unit-III with 300 m³ Capacity – Suited for Late-Stage and Commercial Programs, this expansion supports seamless scale-up manufacturing and enhances our technology transfer capabilities. These developments mark another step forward in our commitment to providing comprehensive, end-to-end CDMO solutions. From pre-clinical stages to commercial production, we’re here to support your journey at every phase. Stop by our stand at #7A26 for a coffee and a chat, and let’s discuss how HONOUR can help bring your breakthroughs to market faster. Come Experience the Science of Partnership and Possibilities! Krishna Chaitanya K Rathan Prasad Achampeta, Ph.D G V Giri Babu #honour #CPHI #CPHIMilan #cdmo #Innovation #Collaboration #pharmaceuticals #ScienceOfPartnershipAndPossibilities
-
Day 2 at CPHI Milan 2024! We had an excellent first day, engaging with so many of you and sharing our latest updates. If you weren't able to visit us yesterday, we look forward to connecting with you today! Stop by Stand #7A26 to explore our recent updates and discover how we can support your projects: - Our new 45,000 ft² state-of-the-art R&D Facility – Check out our video on the big screen to see how this facility enhances our R&D capabilities. - Our 7th Manufacturing Facility – Designed to accelerate your early-phase and mid-phase projects. - New Manufacturing Block at Unit-III with 300 m³ Capacity – Suited for Late-Stage and Commercial Programs, this expansion supports seamless scale-up manufacturing and enhances our technology transfer capabilities. These developments mark another step forward in our commitment to providing comprehensive, end-to-end CDMO solutions. From pre-clinical stages to commercial production, we’re here to support your journey at every phase. Stop by our stand at #7A26 for a coffee and a chat, and let’s discuss how HONOUR can help bring your breakthroughs to market faster. Come Experience the Science of Partnership and Possibilities! Krishna Chaitanya K Rathan Prasad Achampeta, Ph.D G V Giri Babu #honour #CPHI #CPHIMilan #cdmo #Innovation #Collaboration #pharmaceuticals #ScienceOfPartnershipAndPossibilities
-
CPHI 2024 is officially underway! We’re thrilled to be here and excited to unveil some major updates: - Our new 45,000 ft² state-of-the-art R&D Facility – Check out our video on the big screen to see how this facility enhances our R&D capabilities. - Our 7th Manufacturing Facility – Designed to accelerate your early-phase and mid-phase projects. - New Manufacturing Block at Unit-III with 300 m³ Capacity – Suited for Late-Stage and Commercial Programs, this expansion supports seamless scale-up manufacturing and enhances our technology transfer capabilities. These developments mark another step forward in our commitment to providing comprehensive, end-to-end CDMO solutions. From pre-clinical stages to commercial production, we’re here to support your journey at every phase. Stop by our stand at #7A26 for a coffee and a chat, and let’s discuss how HONOUR can help bring your breakthroughs to market faster. And don't forget to keep an eye out for our displays near Hall 7—they'll guide you straight to us! Come Experience the Science of Partnership and Possibilities! Krishna Chaitanya K Rathan Prasad Achampeta, Ph.D G V Giri Babu #honour #CPHI #CPHIMilan #cdmo #Innovation #Collaboration #pharmaceuticals #ScienceOfPartnershipAndPossibilities
-
The countdown begins—just one day until CPHI Milan 2024! HONOUR is delighted to participate in our very first CPHI. We're eager to connect with partners and industry leaders to showcase our innovative CDMO solutions for Small Molecules and Phosphoramidites. We've recently unveiled details about our 7th Manufacturing Facility (link in the comments below), and we have even more exciting updates to share at the event. Be sure to visit us at stand #7A26 to learn how HONOUR can accelerate your breakthroughs. HONOUR at CPHI Milan 2024: 📍 Stand: 7A26 (Contract Manufacturing and Services Zone) 📅 Dates: October 8-10, 2024 📍 Location: Fiera Milano, Italy Keep an eye out for our displays by Hall 7—they'll help you find us easily! To schedule a meeting, please reach out to our team: Krishna Chaitanya, Rathan Prasad Achampeta, Ph.D, G V Giri Babu or email us at connect@honourlab.com. Come Experience the Science of Partnership and Possibilities! #honour #CPHI #CPHIMilan #cdmo #Innovation #Collaboration #pharmaceuticals #ScienceOfPartnershipAndPossibilities
-
Excited to announce our 7th Manufacturing facility! We've acquired a new 40,500 m² manufacturing facility in Hyderabad, bringing our total manufacturing sites to seven. This facility is set to be operational by the end of November 2024. It will enable us to accelerate your early-phase and mid-phase programs with: - One Pilot Line (100 L–500 L Reactor Capacities) for flexible and rapid scale-up - Two Reactor Lines with 18 Reactors (1,000 L–5,000 L Reactor Capacities) for seamless transitions between development phases - Capability to manufacture RSMs, Intermediates, and APIs This expansion strengthens our ability to deliver end-to-end CDMO solutions, supporting your programs from pre-clinical stages to commercial production. By focusing on phase-appropriate development and capabilities, we’re committed to helping you bring your breakthroughs to market faster. Come Experience the Science of Partnership and Possibilities! Krishna Chaitanya K Rathan Prasad Achampeta, Ph.D G V Giri Babu #honour #newfacility #expansion #cdmo #Innovation #Collaboration #pharmaceuticals #ScienceOfPartnershipAndPossibilities
-
Accelerating your breakthroughs at CPHI Milan 2024! We are excited to showcase our innovative CDMO solutions for Small Molecules and Phosphoramidites. Visit us at Stand #7A26 to explore our solutions and learn how we can partner in accelerating your breakthroughs. HONOUR at CPHI Milan 2024: 📍 Stand: 7A26 (Contract Manufacturing and Services Zone) 📅 Dates: October 8-10, 2024 📍 Location: Fiera Milano, Italy To schedule a meeting, please reach out to our team: Krishna Chaitanya K, Rathan Prasad Achampeta, Ph.D, G V Giri Babu or email us at connect@honourlab.com. Come Experience the Science of Partnership and Possibilities! #honour #CPHI #CPHIMilan #cdmo #Innovation #Collaboration #pharmaceuticals #ScienceOfPartnershipAndPossibilities
-
And it’s a wrap! ChemOutsourcing 2024 was an incredible experience connecting with all of you. Thank you to everyone who visited Booth #4 to discuss our CDMO solutions. We’re excited to turn these conversations into lasting partnerships. If we missed you, let’s keep the conversation going — reach out at connect@honourlab.com. Come experience the Science of Partnership and Possibilities! #honour #cdmo #ChemOutsourcing #innovation #partnerships